FDA Adverse Event Malfunction Summary report: N

DIMENSION® CLINICAL CHEMISTRY SYSTEM

MDR report key: 5062231 · Received September 8, 2015

Report

Report Number
2517506-2015-00179
Event Type
Malfunction
Date Received
September 8, 2015
Date of Event
July 24, 2015
Report Date
August 10, 2015
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW
Product Code
CGX
PMA / PMN Number
K132638
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KS, US
Reporter Occupation
MEDICAL TECHNOLOGIST

Narratives

Additional Manufacturer Narrative · 1

ANALYSIS OF THE INSTRUMENT AND INSTRUMENT DATA INDICATE THAT THE CAUSE FOR THE DISCORDANT CREATININE (CR2) ELEVATED RESULTS RELATIVE TO RECOVERIES BY AN ALTERNATE METHODOLOGY IS UNKNOWN. THE ACCOUNT SITE SWITCHED PATIENT TESTING FOR CREATININE TO THE ENZYMATIC CREATININE METHOD. THE ISSUE IS UNDER INVESTIGATION BY SIEMENS HEALTHCARE DIAGNOSTICS INC.

Description of Event or Problem · 1

AN ACCOUNT COMPLAINED OF DISCORDANT CREATININE (CRE2) ELEVATED RESULTS RELATIVE TO RECOVERIES BY AN ALTERNATE METHODOLOGY. THE ACCOUNT HAS NOTED ELEVATED CRE2 RESULT SINCE PLACING THE REAGENT INTO USE ON THE DIMENSION EXL 200 IN (B)(6) 2015. PATIENT RESULTS WERE REPORTED TO PHYSICIANS. THE ACCOUNT REPEATED THE SAMPLES WITH AN ALTERNATE DIMENSION REAGENT (ENZYMATIC CREATININE -EZCR) LOWER RESULTS WERE OBTAINED IN ALIGNMENT WITH PHYSICIAN EXPECTATIONS. PATIENT TREATMENT WAS ALTERED ON THE BASIS OF THE DISCORDANT ELEVATED CRE2 RESULT. PATIENT CHEMOTHERAPY TREATMENTS WERE WITHHELD DUE TO THE SHIFT IN CRE2 VALUES AS COMPARED TO SERUM CREATININE VALUES OBTAINED PRIOR TO USING THE EXL 200. PATIENTS SCHEDULED FOR CT SCANS WERE UNABLE TO RECEIVE CONTRAST MEDIA DUE TO THE SHIFT IN SERUM CREATININE. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES AS A RESULT OF THE DISCORDANT ELEVATED CRE2 RESULTS OR ALTERATIONS IN TREATMENTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
593366 DIMENSION® CLINICAL CHEMISTRY SYSTEM CREATININE FLEX® REAGENT CARTRIDGE CGX SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW FA6093

Patients

Seq Age Sex Outcome Treatment
1